Normal view MARC view ISBD view

Progress in the chemistry of organic natural products [v.107]

Contributor(s): Kinghorn, A. Douglas [ed.] | Falk, Heinz [ed.] | Gibbons, Simon [ed.] | Kobayashi, Jun'ichi [ed.].
Series: Progress in the chemistry of organic natural products ; / edited by A. Douglas Kinghorn; v. 107. Publisher: Switzerland Springer 2018Description: ix, 159p.ISBN: 9783319935058.Subject(s): Organic chemistryDDC classification: 547 | P943 Summary: The first review describes examples of very promising compounds discovered from plants acquired from Africa, Southeast Asia, the Americas, and the Caribbean region with potential anticancer activity. These include plant secondary metabolites of the diphyllin lignan, penta[b]benzofuran, triterpenoid, and tropane alkaloid types. The second review presents 40 more erythrinan alkaloids, which were either new or were missed out in the last major reviews, bringing to a total of 154 known erythrinan alkaloids known to date. The reported pharmacological activities of the new and known alkaloids showed a greater bias towards central nervous system and related activities. Other prominent activities reported were antifeedant or insecticidal, cytotoxicity/anti­tumor/anti­cancer/estrogenic, antiprotozoal, antiinflammatory, antioxidant, antifungal and antiviral activities.
List(s) this item appears in: New Arrival Nov.12th - 18th, 2018
    average rating: 0.0 (0 votes)
Item type Current location Collection Call number Vol info Status Date due Barcode Item holds
Books Books P K Kelkar Library, IIT Kanpur
General Stacks 547 P943 v.107 (Browse shelf) v.107 Available A183984
Total holds: 0

The first review describes examples of very promising compounds discovered from plants acquired from Africa, Southeast Asia, the Americas, and the Caribbean region with potential anticancer activity. These include plant secondary metabolites of the diphyllin lignan, penta[b]benzofuran, triterpenoid, and tropane alkaloid types.

The second review presents 40 more erythrinan alkaloids, which were either new or were missed out in the last major reviews, bringing to a total of 154 known erythrinan alkaloids known to date. The reported pharmacological activities of the new and known alkaloids showed a greater bias towards central nervous system and related activities. Other prominent activities reported were antifeedant or insecticidal, cytotoxicity/anti­tumor/anti­cancer/estrogenic, antiprotozoal, antiinflammatory, antioxidant, antifungal and antiviral activities.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha